Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

[Role of intestinal resection in primary cytoreduction of ovarian cancer].

Balbi GC, Compagna R, Musone R, Cirelli G, Delli Ponti D, Cassese E, Passaro M, Balbi F, Zarcone R.

Minerva Ginecol. 2001 Feb;53(1 Suppl 1):100-1. Italian.

PMID:
11526699
2.

[Cytoreductive surgery in patients with stage IV ovarian carcinoma].

Balbi GC, Compagna R, Musone R, Cirelli G, Sgambato R, Cassese E, Delli Ponti D, Passaro M, Zarcone R.

Minerva Ginecol. 2001 Feb;53(1 Suppl 1):105-9. Italian.

PMID:
11526701
3.

Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.

Gillette-Cloven N, Burger RA, Monk BJ, McMeekin DS, Vasilev S, DiSaia PJ, Kohler MF.

J Am Coll Surg. 2001 Dec;193(6):626-32.

PMID:
11768679
4.

The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.

Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, Park SY.

Gynecol Oncol. 2006 Dec;103(3):977-84. Epub 2006 Jul 11.

PMID:
16837030
5.

Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.

Estes JM, Leath CA 3rd, Straughn JM Jr, Rocconi RP, Kirby TO, Huh WK, Barnes MN 3rd.

J Am Coll Surg. 2006 Oct;203(4):527-32. Epub 2006 Aug 17.

PMID:
17000397
6.

The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience.

Ayhan A, Gultekin M, Taskiran C, Aksan G, Celik NY, Dursun P, Salman MC, Yuce K, Kucukali T.

Am J Obstet Gynecol. 2006 Jan;194(1):49-56.

PMID:
16389009
7.

Is routine appendectomy beneficial in the management of ovarian cancer?

Ayhan A, Tuncer ZS, Tuncer R, YĆ¼ce K, Ayhan A.

Eur J Obstet Gynecol Reprod Biol. 1994 Oct;57(1):29-31.

PMID:
7821499
8.

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer.

Memarzadeh S, Lee SB, Berek JS, Farias-Eisner R.

Int J Gynecol Cancer. 2003 Mar-Apr;13(2):120-4.

PMID:
12657110
9.

Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity.

Heintz AP, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD.

Obstet Gynecol. 1986 Jun;67(6):783-8.

PMID:
3010203
10.

The place of bowel resection in initial debulking surgery for advanced ovarian cancer.

Miller J, Proietto A.

Aust N Z J Obstet Gynaecol. 2002 Nov;42(5):535-7.

PMID:
12495103
11.

Ovarian cancer stage IIIC. Consequences of treatment level on overall and progression-free survival.

Oksefjell H, Sandstad B, Trope C.

Eur J Gynaecol Oncol. 2006;27(3):209-14.

PMID:
16800244
12.

Surgery for ovarian cancer: rationale and guidelines.

Greer BE, Swensen RE, Gray HJ.

J Natl Compr Canc Netw. 2004 Nov;2(6):561-8. Review.

PMID:
19780300
13.

Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer.

Deo SV, Goyal H, Shukla NK, Raina V, Kumar L, Srinivas G.

Indian J Cancer. 2006 Jul-Sep;43(3):117-21.

14.

The effect of bowel resection on survival in advanced epithelial ovarian cancer.

Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N.

Gynecol Oncol. 2001 Nov;83(2):286-91.

PMID:
11606086
15.

Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.

Einenkel J, Ott R, Handzel R, Braumann UD, Horn LC.

Int J Gynecol Cancer. 2009 Oct;19(7):1288-97. doi: 10.1111/IGC.0b013e3181a3a833.

PMID:
19823067
16.

[Epithelial ovarian cancer--preoperative assessment of Ca 125 levels as an independent prognostic factor].

Ivanov S, Ivanov S.

Akush Ginekol (Sofiia). 2003;42(3):16-9. Bulgarian.

PMID:
12858485
17.

Initial surgical management of advanced epithelial ovarian cancer.

Benjamin I, Rubin SC.

Cancer Invest. 1997;15(3):270-6. Review. No abstract available.

PMID:
9171862
18.

Morbidity of cytoreductive surgery in the elderly.

Wright JD, Herzog TJ, Powell MA.

Am J Obstet Gynecol. 2004 May;190(5):1398-400.

PMID:
15167848
19.

Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.

Salani R, Zahurak ML, Santillan A, Giuntoli RL 2nd, Bristow RE.

Gynecol Oncol. 2007 Dec;107(3):495-9. Epub 2007 Sep 12.

PMID:
17854870
20.

Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?

Saygili U, Guclu S, Uslu T, Erten O, Demir N, Onvural A.

Gynecol Oncol. 2002 Jul;86(1):57-61.

PMID:
12079301

Supplemental Content

Support Center